Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaRégis Peffault de Latour, Antonio M. Risitano, Annapaola Iori et al.|New England Journal of Medicine|2022Cited by 309
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutationAlberto Álvarez‐Larrán, C. Besses, Arturo Pereira et al.|Haematologica|2016Cited by 149
Use of eltrombopag in aplastic anemia in EuropeJakob Passweg, Matyas Ecsedi, Étienne Lengliné et al.|Annals of Hematology|2019Cited by 38
Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathiesAnne‐Catherine Radauer‐Plank, Magdalena Balcerek, Tamara Diesch et al.|Pediatric Blood & Cancer|2023Cited by 11
Transplant Outcomes for Acute Myeloid Leukemia or Myelodysplastic Syndromes Secondary to Acquired Aplastic Anemia or Paroxysmal Nocturnal Hemoglobinuria: A Report from the EBMT Severe Aplastic Anemia Working PartyPedro Henrique Prata, Régis Peffault de Latour, Dirk‐Jan Eikema et al.|Blood|2023Cited by 2